Secondhand Smoke Statistics and Health Impact Data for 2026

Secondhand smoke statistics and health impact data for 2026 confirm what four decades of research have made unambiguous: there is no safe level of exposure. In the United States alone, secondhand smoke causes more than 41,000 deaths per year among non-smokers — including approximately 34,000 from heart disease and 7,300 from lung cancer (CDC, 2024). Globally, secondhand smoke exposure kills more than 1.2 million non-smokers annually, according to the World Health Organization’s 2023 tobacco report. Every death is entirely preventable.

This data roundup synthesises the current evidence base on secondhand smoke (SHS) health effects, covering mortality, disease burden, exposure prevalence, the heightened risks to children, economic costs, and policy effectiveness. Sources include the CDC, WHO, American Lung Association, American Cancer Society, and the Global Burden of Disease Study 2021, published in Respiratory Research (2025).

What Is Secondhand Smoke: Composition and Exposure

Secondhand smoke is a mixture of sidestream smoke (emitted from the burning tip of a cigarette) and mainstream smoke (exhaled by the smoker). Sidestream smoke is chemically more concentrated than mainstream smoke and contains over 7,000 chemical compounds, including at least 70 known carcinogens — among them arsenic, benzene, chromium, and formaldehyde (CDC, 2024).

Exposure pathways include:

• Indoor environments: Homes, cars, workplaces, and hospitality venues where smoking occurs.
• Outdoor proximity: Enclosed outdoor spaces where smoke accumulates (outdoor dining areas, building entrances).
• Third-hand smoke: Tobacco toxins that persist on surfaces, furniture, and fabrics long after smoking has stopped — a significant risk for infants and young children who crawl and put objects in their mouths.

The Surgeon General has concluded that there is no risk-free level of secondhand smoke exposure. Even brief, transient exposures can trigger acute cardiovascular events in vulnerable individuals (US Surgeon General’s Report, 2006; reaffirmed 2020).

Mortality Data: Deaths Attributable to SHS

The scale of secondhand smoke mortality is well-established and has not declined proportionately with the fall in overall smoking rates, because population ageing and existing disease burden sustain risk even as new exposure decreases.

The global figure of 1.2 million non-smoker deaths per year is striking: secondhand smoke kills more people than malaria (approximately 600,000 deaths per year, WHO 2023) and road traffic accidents (approximately 1.19 million, WHO 2023) — making it one of the deadliest environmental health hazards on the planet, despite being entirely preventable through policy and behaviour change.

Disease Burden: Conditions Caused by SHS

Secondhand smoke is causally linked to a broad spectrum of serious conditions in non-smoking adults and children. The CDC’s evidence base classifies these as “sufficient evidence” — the highest level of causal certainty.

In Adults

• Coronary heart disease: Non-smokers exposed to SHS have a 25–30% increased risk of developing coronary heart disease (CDC, 2024). The mechanism involves endothelial damage, platelet aggregation, and accelerated atherosclerosis triggered even by brief exposure.
• Stroke: SHS increases stroke risk by approximately 20–30% in exposed non-smokers.
• Lung cancer: Non-smokers regularly exposed to SHS have a 20–30% increased risk of developing lung cancer versus unexposed non-smokers (American Cancer Society, 2024).
• Reproductive health effects: SHS exposure in pregnant women is associated with low birth weight, preterm birth, and spontaneous abortion.
• Chronic respiratory disease: Increased rates of asthma onset, COPD progression, and reduced lung function in chronically exposed adults.

In Children

Children are at heightened risk from SHS because their lungs are still developing and their immune systems are less mature. The CDC identifies the following conditions with sufficient evidence of causation:

• Sudden infant death syndrome (SIDS)
• Acute respiratory infections (pneumonia, bronchitis, bronchiolitis)
• Middle ear disease (glue ear / otitis media with effusion)
• More severe and more frequent asthma attacks
• Respiratory symptoms (wheeze, cough, shortness of breath)
• Slowed lung growth — with potential lifetime effects on respiratory capacity

Children and Secondhand Smoke: A Disproportionate Risk

Children cannot choose their environment, making adult smoking behaviour directly responsible for paediatric health outcomes. The statistics are sobering.

In the US:

• Approximately 25.6% of children aged 3–11 years are exposed to secondhand smoke (NHANES data, 2020).
• About 40% of children are exposed to SHS in some form at home or in the car (American Lung Association, 2023).
• SHS is a leading contributor to the estimated 150,000–300,000 new cases of bronchitis and pneumonia in children under 18 months of age annually in the US.
• Children of smokers miss approximately 1.4 million more school days per year due to respiratory illness than children in non-smoking households.

Globally, children in LMICs are at the highest risk: household cooking fires and poor ventilation compound SHS exposure in densely populated areas. The GBD Study 2021 found that the child burden of SHS has not declined as sharply as adult SHS-related mortality in high-income countries, partly due to persistently high home exposure rates.

The connection between parental smoking and the health of children is one of the strongest motivators for quitting among parents. Our step-by-step quit smoking plan addresses family motivation strategies directly, and our guide on how to support someone quitting smoking covers how families can work together.

Exposure Prevalence: Who Is Still at Risk?

Despite dramatic reductions in workplace and public venue smoking in many countries, SHS exposure remains widespread — particularly in residential settings that are harder to regulate.

A critical data point: tobacco smoke concentration inside a car with the windows up and one smoker present can reach levels 10 times higher than a smoky bar, according to research cited by the CDC. This makes vehicle exposure — especially for children — a major concern even in countries with broad smoke-free indoor policies.

Global Burden of Disease Data (GBD Study 2021)

A comprehensive 2025 analysis published in Respiratory Research examined SHS-attributable disease burden across 204 countries and territories from 1990 to 2021, using data from the Global Burden of Disease Study 2021 (Respiratory Research, 2025).

Key findings from this landmark study:

• Since 2010, the number of deaths attributable to SHS exposure has increased in absolute terms due to population growth and population ageing — even as smoking rates have fallen.
• Ischaemic heart disease remains the leading SHS-attributable cause of death globally.
• Lower respiratory infections in children remain a major SHS-attributable disease burden in LMICs.
• East Asia and South Asia carry the largest absolute SHS disease burden, driven by high smoking rates in adult males and dense housing.
• Eastern Europe continues to have among the highest SHS-attributable mortality rates in the developed world, reflecting slower progress on smoke-free policies.

Economic Impact of Secondhand Smoke

The economic costs of secondhand smoke extend beyond healthcare expenditure to include lost productivity, childcare due to illness, and environmental costs.

• US direct economic cost of SHS: Approximately $7 billion per year in premature death costs (CDC, 2024).
• Paediatric healthcare costs: SHS-related lower respiratory infections in US children generate hundreds of millions in annual treatment and hospitalisation costs.
• Employer costs: Non-smoking employees in workplaces with residual SHS exposure show higher absenteeism than those in fully smoke-free environments.
• Property costs: Third-hand smoke contamination reduces property values and creates remediation costs in rental housing — estimates range from $2,000–$20,000 per unit for deep cleaning after heavy smokers.

When evaluating the full cost of smoking, SHS represents a substantial externality — costs borne entirely by non-smoking individuals who made no choice to accept the risk. This externality underpins the public health and legal rationale for comprehensive smoke-free policies.

Smoke-Free Policies: What the Data Shows

Comprehensive smoke-free laws are the most effective single policy intervention for reducing SHS exposure and its health effects. The evidence base is extensive.

Hospitalisation Rates

Multiple studies from the US, UK, and Ireland have documented 10–20% reductions in acute myocardial infarction (heart attack) hospitalisations within 1–2 years of implementing comprehensive workplace and hospitality smoke-free legislation. Scotland’s 2006 smoking ban was associated with a 17% reduction in acute coronary syndrome admissions within one year.

Childhood Asthma Hospital Admissions

England’s 2007 workplace smoking ban was followed by a significant reduction in childhood asthma-related hospital admissions, demonstrating that policy-level changes at adult exposure venues translate to measurable paediatric health improvements.

Current Policy Gaps

As of 2024, the WHO estimates that fewer than 20% of the world’s population is covered by comprehensive smoke-free laws covering all indoor public places. Key remaining exposure gaps include:

• Private homes — not addressed by any smoke-free legislation in most countries.
• Multi-unit housing — variable coverage even in smoke-free-leading nations.
• Outdoor dining and entertainment venues in many jurisdictions.
• LMICs — where comprehensive smoke-free laws remain the exception rather than the rule.

Understanding SHS data is closely linked to understanding the full disease impact of smoking, explored in our articles on what happens to your body when you stop smoking and whether lungs can heal after years of smoking. For the costs that SHS imposes on healthcare systems, see our analysis of smoking-related healthcare costs for 2026.

Frequently Asked Questions